Literature DB >> 19564856

Interactions between angiotensin II and arginine vasopressin in water homeostasis.

Robert W Schrier1.   

Abstract

Mice deficient in the angiotensin II type 1a (AT(1a)) receptor demonstrate a vasopressin-resistant nephrogenic diabetes insipidus. These knockout mice exhibit a threefold increase in 24-h urine excretion. Neither 2 weeks of exogenous vasopressin nor 5 days of fluid restriction reversed this polyuric state. This nephrogenic diabetes insipidus was associated with reductions in adenylyl cyclase protein and in the phosphorylated mitogen-activated protein kinase extracellular signal-regulated kinase 1/2. The results support an important interaction between vasopressin and angiotensin II in maximal urinary concentration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564856      PMCID: PMC4319672          DOI: 10.1038/ki.2009.103

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

Review 1.  Body water homeostasis: clinical disorders of urinary dilution and concentration.

Authors:  Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2006-05-31       Impact factor: 10.121

2.  Increased AQP2 targeting in primary cultured IMCD cells in response to angiotensin II through AT1 receptor.

Authors:  Yu-Jung Lee; In-Kyung Song; Kyung-Jin Jang; Jakob Nielsen; Jørgen Frøkiaer; Søren Nielsen; Tae-Hwan Kwon
Journal:  Am J Physiol Renal Physiol       Date:  2006-08-08

3.  Abnormal water metabolism in mice lacking the type 1A receptor for ANG II.

Authors:  M I Oliverio; M Delnomdedieu; C F Best; P Li; M Morris; M F Callahan; G A Johnson; O Smithies; T M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2000-01

4.  Stimulation of ADH release by the renin-angiotensin system.

Authors:  J P Bonjour; R L Malvin
Journal:  Am J Physiol       Date:  1970-06

5.  Angiotensin II AT1 receptor blockade decreases vasopressin-induced water reabsorption and AQP2 levels in NaCl-restricted rats.

Authors:  Tae-Hwan Kwon; Jakob Nielsen; Mark A Knepper; Jørgen Frøkiaer; Søren Nielsen
Journal:  Am J Physiol Renal Physiol       Date:  2004-12-07

6.  Angiotensin II potentiates vasopressin-dependent cAMP accumulation in CHO transfected cells. Mechanisms of cross-talk between AT1A and V2 receptors.

Authors:  C Klingler; N Ancellin; M B Barrault; A Morel; J M Buhler; J M Elalouf; E Clauser; C Lugnier; B Corman
Journal:  Cell Signal       Date:  1998-01       Impact factor: 4.315

7.  Effects of angiotensin II on plasma antidiuretic hormone and renal water excretion.

Authors:  W L Henrich; B R Walker; W A Handelman; A L Erickson; P E Arnold; R W Schrier
Journal:  Kidney Int       Date:  1986-10       Impact factor: 10.612

8.  AT1a receptor knockout in mice impairs urine concentration by reducing basal vasopressin levels and its receptor signaling proteins in the inner medulla.

Authors:  Xiao C Li; Yuan Shao; Jia L Zhuo
Journal:  Kidney Int       Date:  2009-04-22       Impact factor: 10.612

9.  Effect of primary polydipsia on aquaporin and sodium transporter abundance.

Authors:  Melissa A Cadnapaphornchai; Sandra N Summer; Sandor Falk; Joshua M Thurman; Mark A Knepper; Robert W Schrier
Journal:  Am J Physiol Renal Physiol       Date:  2003-07-22

Review 10.  Angiotensin, thirst, and sodium appetite.

Authors:  J T Fitzsimons
Journal:  Physiol Rev       Date:  1998-07       Impact factor: 37.312

  10 in total
  9 in total

1.  Targeting the Trafficking of Kidney Water Channels for Therapeutic Benefit.

Authors:  Pui W Cheung; Richard Bouley; Dennis Brown
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-27       Impact factor: 13.820

2.  Interaction between vasopressin and angiotensin II in vivo and in vitro: effect on aquaporins and urine concentration.

Authors:  Weidong Wang; Chunling Li; Sandra Summer; Sandor Falk; Robert W Schrier
Journal:  Am J Physiol Renal Physiol       Date:  2010-06-24

3.  Molecular mechanisms of angiotensin II stimulation on aquaporin-2 expression and trafficking.

Authors:  Chunling Li; Weidong Wang; Christopher J Rivard; Miguel A Lanaspa; Sandra Summer; Robert W Schrier
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-16

4.  Vasopressin/V2 receptor stimulates renin synthesis in the collecting duct.

Authors:  Alexis A Gonzalez; Flavia Cifuentes-Araneda; Cristobal Ibaceta-Gonzalez; Alex Gonzalez-Vergara; Leonardo Zamora; Ricardo Henriquez; Carla B Rosales; L Gabriel Navar; Minolfa C Prieto
Journal:  Am J Physiol Renal Physiol       Date:  2015-11-25

5.  Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure.

Authors:  Xiangning Cui; Jian Zhang; Yubo Li; Yuxiu Sun; Jian Cao; Mingjing Zhao; Yizhou Zhao; Xin Zhao; Yaoyao He; Anbang Han
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-17       Impact factor: 2.629

Review 6.  Multiple Aspects of Inappropriate Action of Renin-Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases.

Authors:  Ewa Szczepanska-Sadowska; Agnieszka Wsol; Agnieszka Cudnoch-Jedrzejewska; Katarzyna Czarzasta; Tymoteusz Żera
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

Review 7.  Tissue Renin-Angiotensin systems: a unifying hypothesis of metabolic disease.

Authors:  Jeppe Skov; Frederik Persson; Jørgen Frøkiær; Jens Sandahl Christiansen
Journal:  Front Endocrinol (Lausanne)       Date:  2014-02-28       Impact factor: 5.555

Review 8.  Oxytocin and cardioprotection in diabetes and obesity.

Authors:  Marek Jankowski; Tom L Broderick; Jolanta Gutkowska
Journal:  BMC Endocr Disord       Date:  2016-06-07       Impact factor: 2.763

Review 9.  Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders.

Authors:  Ewa Szczepanska-Sadowska; Katarzyna Czarzasta; Agnieszka Cudnoch-Jedrzejewska
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.